anti-CTLA-4

Browsing: anti-CTLA-4

October 15, 2020

Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1)…

September 14, 2020

Results from a Phase II trial led by researchers at The University of Texas MD…

December 11, 2019

Treatment with the investigational anti-CTLA-4 agent tremelimumab showed clinical responses in patients with pretreated metastatic…

April 18, 2018

Just like people, some T cells have excellent memories. These subtypes known as memory T…